ScholarWorks@SUNGKYUNKWAN UNIVERSITY: CHO, EUN YOON

Detailed Information

CHO, EUN YOON (조은윤)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Immunohistochemistry:13||Breast neoplasms:13||Breast cancer:12||Breast:10||breast cancer:9||Prognosis:5||prognosis:5||Magnetic resonance imaging:4||Neoadjuvant chemotherapy:4||EGFR:4||neoadjuvant chemotherapy:3||Mutation:3||Pathologic complete response:3||Metastasis:3||sonography:3||MRI:3||Neoadjuvant therapy:3||Chemotherapy:3||breast:3||HER2:3||BRCA1:3||ErbB2:3||Cyclin D1:3||EpsteinBarr virus:2||Triplenegative breast cancer:2||triple negative breast cancer:2||triplenegative breast cancer:2||cytology:2||diagnosis:2||Human epidermal growth factor receptor 2:2||ErbB2 receptor:2||embolism:2||Lung cancer:2||Radiotherapy:2||Receptor:2||Ultrasound:2||Carcinoma:2||Nomogram:2||MR imaging:2||Nonsmall cell lung cancer:2||Observer variation:2||Sonography:2||Insulinlike growth factor 1 receptor:2||recurrence:2||breast neoplasm:2||Extramammary Paget disease:2||carcinoma:2||<:2||CT:2||Ki67:2||Phosphatidylinositol 3kinases:2||Breast neoplasm:2||methylation:2||Her2:2||Digital pathology:1||Diseasefree:1||Diseasefree survival:1||ER:1||ER (1D5, 6F11 and SP1):1||ER status:1||Equivocal:1||Esophageal cancer:1||Estrogen receptors:1||Exosomes:1||Extracellular vesicles:1||Extramammary:1||Extranodal natural killer/Tcell nasal type lymphoma:1||FHIT:1||FISH:1||FOXM1:1||FOXO3a:1||Fibromyxoid:1||Fineneedle aspiration:1||Forkhead box protein:1||Formalinfixed paraffinembedded (FFPE):1||Gene expression:1||Genes:1||Giant cell tumor:1||H3K4 methylation:1||HER2:1||HER2 gene:1||HER2overexpressing breast cancer:1||HLADR Antigens:1||HPV DNA chip typing:1||Hepatocellular carcinoma:1||Her2:1||Hormonal receptor:1||Hormone receptor:1||Hormone receptorpositive breast cancer:1||Immune checkpoint inhibitors:1||Immune gene signature:1||Immunohistoch:1||In situ hybridization:1||Informatics:1||Integrin:1||Interobserver variability:1||Intracystic papillary carcinoma:1||Invasive:1||Invasive breast cancer:1||Invasive lobular carcinoma:1||Invasive micropapillary carcinoma:1||Ki67 proliferation index:1||Knee:1||LAG3:1||LC3:1||LKB1:1||Lobular carcinoma:1||Lung:1||Lung, CT:1||Lymph node:1||MIB1:1||MLL2:1||MR spectroscopy:1||Machine learning:1||Magnetic resonance (MR):1||Male breast:1||Male breast cancer:1||Metaplastic carcinoma:1||Metastatic breast cancer:1||Metformin:1||Methylation:1||Mitosis:1||Molecular diagnostic techniques:1||Molecular subtype:1||Mucinous cystadenocarcinoma:1||Multimodality:1||Multicenter:1||Multiplicity:1||Mycobacterium avium complex:1||Neoadjuvant:1||Neoplasm:1||Neoplasm metastasis:1||Neoplasms:1||Nerve growth factor:1||Nonnodal mass:1||Ossifying fibroma:1||PD1:1||PDL1:1||PET CT:1||PET/CT:1||PR (1E2):1||Paget disease:1||Papillary breast lesion:1||Papillomavirus, human:1||Patterns of failure:1||Peribronchial myofibroblas:1||Peritoneum:1||Perivascular epithelioid cell neoplasms:1||Phyllodes tumor:1||Polycystic Kidney Diseases:1||Progesterone receptors:1||Prognostic biomarker:1||Prognostic markers:1||Pure mucinous adenocarcinoma:1||RTPCR:1||RUNX1:1||Radio frequency:1||Recurrence:1||Relapse pattern:1||Relapsefree survival:1||Response:1||SIRT1:1||SIRT1 inhibitor:1||SIRT6:1||Secretory carcinoma:1||Sentinel lymph node biopsy:1||Shallow whole genome sequencing (sWGS):1||Skin changes:1||Soft tissue infiltration:1||Spine:1||Survival:1||Survival outcomes:1||Tcell nasaltype lymphoma:1||TCHP:1||TFE3:1||TGF:1||TNM staging:1||TWIST1:1||Thermal injury:1||Thymidine phosphorylase:1||Thymidylate synthase:1||Thyroid:1||Trachea:1||Triple negative breast cancer:1||Triple negative breast cancer (TNBC):1||Triplenegative breast neoplasms:1||Triplenegative cancer:1||Tumor:1||Tumor grade:1||Tumor stroma:1||Tumor suppressor protein p53:1||Tumorinfiltrating lymphocytes:1||Ul:1||Ultrasonography:1||Venous malformation:1||Whole slide imaging:1||ablation:1||adenoid cystic carcinoma:1||adenoma:1||adipocytic differentiation:1||adjuvant chemotherapy:1||airway:1||alphamethylacylCoA racemase:1||animal studies:1||atypical mycobacteria:1||automation:1||axilla:1||betacatenin:1||biomarker:1||brain metastasis:1||breast metastasis:1||breast neoplasms:1||breast ultrasound:1||cardiovascular disease:1||cardiovascular imaging:1||case report:1||cell adhesion molecule:1||chemical:1||chemotherapy:1||chest imaging:1||chromogenic in situ hybridization:1||collagen induced arthritis:1||congenital:1||core needle biopsy:1||cyclin D1:1||cystathionine betasynthase:1||desmoid:1||ductal:1||elastography:1||epidemiology:1||erbB2:1||exosomes:1||expression assay:1||extracellular vesicles:1||extranodal natural killer:1||falsenegative rate:1||fatty liver:1||fibromatosis:1||fine needle aspiration:1||fluorescence:1||giant cell tumors:1||hemophagocylic:1||hepatocellular carcinoma:1||highgrade serous carcinoma:1||hypoxia:1||immune checkpoint inhibitor:1||immunohistochemistry:1||in situ hybridization:1||ischemia:1||lung cancer:1||lung disease:1||lung neoplasms:1||lymphangiogenesis:1||lymphatic metastasis:1||lymphocytes:1||lymphoepitheliomalike carcinoma:1||lymphohistiocytosis:1||lymphoma:1||mTOR:1||macrophages:1||metachronous second primary neoplasm:1||metastasis:1||metastatic breast carcinoma:1||metastatic thymoma:1||metformin:1||miR106b:1||miR17:1||molecular subtypes:1||monoclonal antibody D240:1||mucinous:1||multifactorial probabilitybased analysis:1||musculoskeletal imaging:1||nCounter mRNA expression assay:1||neoadjuvant chemotherapy:1||neoplasm:1||neoplasms, multiple primary:1||nextgeneration sequencing:1||nonnodal mass:1||nonsmall cell lung cancer (NSCLC):1||nucleotidediphosphate kinase:1||ovarian serous neoplasms:1||ovary:1||p14ARFMDM2p53 pathway:1||p16:1||panniculitislike Tcell lymphoma:1||papillary lesion:1||platinum chemotherapy:1||pleura:1||polycystic kidney disease 1 protein:1||polycystin1:1||pregnancy:1||prognostic biomarker:1||prognostic factor:1||pulmonary artery sarcoma:1||pulmonary coin lesion:1||pulmonary thromboembolism:1||radio frequency:1||radiotherapy:1||recurrent thymoma:1||residual cancer burden:1||rheumatoid arthritis:1||secondary:1||secretory carcinoma:1||serous neoplasms:1||shearwave elastography:1||signet ring cell:1||smoking:1||solitary fibrous tumour:1||spine:1||stomach:1||surgical excision:1||survival:1||synchronous:1||tenovin6:1||thermal injury:1||thyroid gland:1||triplenegative breast neoplasm:1||tuberculoma:1||tuberculosis:1||tumor response:1||tumor stroma:1||tumorInfiltrating:1||vacuum biopsy:1||variants of uncertain significance:1||#946:1||vascular endothelial growth factor A:1||&:1||catenin:1||= 1 cm Invasive breast cancer:1||= 1 cm i:1||A proliferationinducing ligand:1||ACMG standards and guidelines:1||AJCC 8th edition:1||ASCO/CAP guidelines:1||Ablation:1||Adenocarcinoma:1||Adjuvant chemotherapy:1||Adjuvant treatment:1||Agreement rate:1||AmpliSeq:1||Animal studies:1||Artificial intelligence:1||Autophagy:1||Axilla:1||B7H1 antigen:1||BIRADS:1||BRAF mutation:1||BRCA2:1||Beclin1:1||Bmi1:1||Bone:1||Brain metastases:1||Bre:1||Breast conserving surgery:1||CXC motif chemokine ligand 13:1||CD163 protein:1||CISH:1||CSIHC4:1||CTNNB1:1||Capecitabine:1||Casecontrol study:1||Cell cycle:1||Cell cycle regulator:1||Chip:1||Classification:1||Comparison:1||Congenital tumor:1||Congenital vascular malformation:1||Copy number (CN) and breast cancer:1||Core needle biopsy:1||Counting:1||Cutaneous lymphoma:1||Cyclin D2:1||Cytology:1||DCIS:1||DNA methylation:1||DNA sequencing:1||Dermal:1||Differential:1||

STATISTICS: Total View :5,243,724; Today View :298

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE